Volume–Function Analysis (LiMAx Test) in Patients with HCC and Cirrhosis Undergoing TACE—A Feasibility Study

BACKGROUND: Transarterial chemoembolization (TACE) is an important therapy for hepatocellular carcinoma (HCC) in cirrhosis. In particular in advanced cirrhosis, post-TACE hepatic failure liver (PTHF) failure may develop. Currently, there is no standardization for the periinterventional risk assessme...

Descripción completa

Detalles Bibliográficos
Autores principales: Reichert, Matthias Christian, Massmann, Alexander, Schulz, Antje, Buecker, Arno, Glanemann, Matthias, Lammert, Frank, Malinowski, Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236026/
https://www.ncbi.nlm.nih.gov/pubmed/32816218
http://dx.doi.org/10.1007/s10620-020-06535-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236026/
https://www.ncbi.nlm.nih.gov/pubmed/32816218
http://dx.doi.org/10.1007/s10620-020-06535-5

Ejemplares similares